Infigratinib vs Trastuzumab
Infigratinib vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Infigratinib and Trastuzumab.
Mechanism of Action
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Trastuzumab β 28 days.
Chemical Properties
Type: Infigratinib β Small molecule; Trastuzumab β Antibody.